{
  "id": 9627410,
  "title": "Utah Medical offers to buy back shares at $75 premium",
  "url": "https://urgent.news/2026/09/24/utah-medical-offers-to-buy-back-shares-at-75-premium",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-24T20:52:28.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/utah-medical-offers-to-buy-back-shares-at-75-premium-93CH-4916244"
  },
  "original_language": "en",
  "account": "Utah Medical Products Inc. (UTMD) has initiated a tender offer to repurchase up to 650,000 of its common shares at $75.00 per share, according to a press release. This offer price is 17% higher than the average daily closing price over the past year and 21% higher than the average for the past two years. The board of directors has approved the tender but has not recommended that shareholders exercise their option to tender their shares. The offer is set to expire on October 7 at 5:00 p.m. New York City time, unless extended. In the first half of 2026, UTMD experienced a 12% decline in sales and a 13% drop in net profits compared to the same period in 2025. The company's EBITDA for the most recent twelve months stood at $15,703,744. CEO Kevin Cornwell expressed that he believes UTMD's shares are currently undervalued, even at the tender price of $75.00. Computershare Trust Company is the depositary for the offer, while Georgeson LLC serves as the information agent. The purpose of this offer is to provide liquidity for shareholders who wish to sell their shares at a premium over recent trading prices. Utah Medical Products specializes in developing, manufacturing, and marketing disposable and reusable specialty medical devices, with a particular emphasis on healthcare products for women and babies. This news article was AI-generated with editorial review.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}